Confirmed Partners & Exhibitors

Industry Opportunities
Confirmed Partners & Exhibitors

Organized By

Confirmed Partners & Exhibitors

We would like to thank the following companies for their support.

Platinum

Gold

Silver

Bronze

Supporters

Exhibitors

1Cell.Ai

1Cell.Ai

1Cell.Ai, based in Foster City, California, is at the forefront of precision oncology, driving personalized cancer therapy with its innovative single cell multi-omics platform combining cutting-edge molecular science with advanced AI technology. This platform delivers real-time information allowing for the comprehensive analysis of individual cancer cells across multiple molecular levels, including genomics, transcriptomics, proteomics, and epigenomics. This technology provides deep insights into tumor heterogeneity, enabling the identification of rare cell populations that may drive metastasis or resistance to therapy, and tailoring treatments to improve patient outcomes.
1cell.ai.com

Agilent Technologies

Agilent Technologies

Agilent is a global leader in life sciences and diagnostics. Employing approximately 18,000 people worldwide, Agilent operates in six key markets. Its mission is to improve quality of life through scientific innovation. With facilities and sales offices worldwide, Agilent delivers high-quality solutions to customers in 110 countries.
agilent.com

ANGLE

ANGLE

Circulating tumour cells (CTCs) can provide critical insights in cancer research by enabling duel analysis of CTC-DNA and ctDNA from a single blood tube, as well as RNA and protein analyses that advance precision oncology. ANGLE’s proprietary Parsortix® system offers an optimal solution for capturing and harvesting CTCs directly from whole blood, supported by over 100 peer-reviewed publications across 42 independent cancer centres and 24 cancer types. Alongside supplying the Parsortix system for research use, ANGLE delivers specialised clinical and translational services through its accredited laboratories, supporting biomarker discovery, drug development and customised liquid biopsy assay validation.
angleplc.com

Bio-Rad Laboratories

Bio-Rad offers the Genesis system for isolation of rare cells from liquid biopsy, including circulating tumor cells (CTCs). Alongside the ddSEQ for scRNA-seq or one of Bio-Rad's best-in-class ddPCR systems, these platforms empower researchers to capture scarce populations, resolve cellular heterogeneity, and unlock insights across oncology, immunology, and translational research.
bio-rad.com

Boehringer Ingelheim

BillionToOne

BillionToOne

Northstar by BillionToOne is a blood-based liquid biopsy platform that delivers ultra-sensitive genomic and methylation analysis to support personalized cancer care. Powered by proprietary QCT™ technology, Northstar Select® provides comprehensive genomic profiling to guide therapy selection, while Northstar Response® enables real-time monitoring of treatment efficacy through tumor-specific methylation tracking. Together, they offer a seamless, non-invasive solution for oncology practices—delivering single-molecule precision and faster insights to help clinicians make more informed decisions.
northstaronc.com

Burning Rock Dx LLC

Burning Rock Dx LLC

Burning Rock Dx (NASDAQ: BNR) is a global diagnostics company focusing on applying next-generation sequencing (NGS) technology in precision oncology. Guided by the mission of “Guard Life via Science,” Burning Rock offers solutions covering the entire precision oncology development cycle through an internally developed NGS-based assay portfolio for both tissue and blood samples, along with a robust in-house database to help facilitate clinical trial studies and research. Burning Rock provides dedicated services to pharmaceutical partners, encompassing genomic data solutions, clinical trial solutions, precision patient recruitment, and companion diagnostics (CDx) development and commercialization.
us.brbiotech.com

Caris Life Sciences®

Caris Life Sciences®

Caris Life Sciences® is a leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Caris has created the large-scale, multi-modal database and computing capability needed to analyze and unravel the molecular complexity of disease.
carislifesciences.com

Foundation Medicine

Foundation Medicine is a pioneer in molecular profiling for cancer, working to shape the future of clinical care and research. We collaborate with a broad range of partners across the cancer community and strive to set the standard for quality, scientific excellence, and regulatory leadership. Our deep understanding of cancer biology helps physicians make informed treatment decisions for their patients and empowers researchers to develop new medicines. We are driven to help our partners find answers and take action as we work to transform cancer care.
foundationmedicine.com

GT Molecular

GT Molecular

GT Molecular provides high-performance, ultrasensitive digital and Real-Time PCR (RUO) assays for pathogen quantification, advancing cancer research, gene therapy quantification, and performing minimal residual disease (MRD) monitoring and surveillance. Our multiplex oncology and vector copy number (VCN) assay kits are optimized and validated using real patient samples, providing high-performance, easy-to-use results with all primers, probes, and controls included. Sample logistics management, PCR and NGS testing services are also available. Our customers include universities, hospitals, government entities, public health and commercial testing laboratories, biopharma and more.
gtmolecular.com

Menarini Silicon Biosystems

Menarini Silicon Biosystems (MSB) is the only CLIA lab that offers circulating tumor cell (CTC) enumeration and phenotyping with CellSearch® as well as comprehensive genomic profiles of tumor cell-fee DNA and RNA (cfDNA/RNA) with MenariniSearch.
CellSearch® is the Gold Standard of CTC technology offering a minimally invasive approach to follow your cancer patient’s journey. MenariniSearch detects a broader range of genetic alterations, discovering novel biomarkers and therapeutic targets. MenariniSearch tests use NGS powered by AI and are available for most cancers.
MSB’s tests are CLIA/CAP ISO15189 accredited LDTs can be performed on peripheral blood, cerebrospinal fluid, tissue, and bone marrow.
siliconbiosystems.com

Natera

Natera

Signatera is a custom-built circulating tumor DNA (ctDNA) test for molecular residual disease (MRD) assessment and treatment monitoring and in patients previously diagnosed with cancer. Signatera’s performance has been clinically validated in multiple solid tumors including colorectal, breast, and bladder cancers as well as for immunotherapy response monitoring.
natera.com

Norgen Biotek Corp.

Norgen Biotek Corp.

At Norgen Biotek Corp., we deliver innovative solutions for sample collection, preservation, extraction, and detection, empowering groundbreaking discoveries. Backed by expert support and trusted global collaborations, we provide reliable products and guidance to help you achieve consistent results throughout your scientific journey.
norgenbiotek.com

Nuvation Bio

Nuvation Bio

Nuvation Bio is a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology. Our vision is to significantly change the treatment of cancer by developing novel and differentiated medicines that provide truly meaningful improvements in quality of life and survival for people around the world.
nuvationbio.com

Omega Bio-Tek

For over 25 years, Omega Bio-tek has been an industry-leading provider of DNA/RNA purification kits and equipment for clinical, biotechnology, and genomics research. Operating under ISO 9001:2015 and ISO 13485:2016 certification, Omega Bio-tek provides a diversified product portfolio for low- and high-throughput purification of high-quality nucleic acids from a wide variety of sample types. Omega Bio-tek’s products and automation support services are used in thousands of universities and research laboratories in over 100 countries worldwide.
Visit omegabiotek.com for more information on our products and services.

OncoHost

OncoHost

OncoHost is transforming the approach to precision medicine with PROphet®, a plasma-based, proteomic pattern analysis tool. Its initial offering, the PROphetNSCLC™ test uses one blood sample to guide first-line immunotherapy decisions in NSCLC, delivering personalized treatment insights that that help physicians optimize care and improve patient survival outcomes.
oncohost.com

Portamedic

Portamedic

Portamedic completes nationwide mobile phlebotomy services. Each year we complete over 2 million mobile blood draws. With coverage in all 50 states and Puerto Rico we can see your patients anytime and anywhere. We work with many companies in the liquid biopsy and cancer surveillance spaces.
portamedic.com

SAGA Diagnostics

SAGA Diagnostics

SAGA Diagnostics® is redefining the early detection of molecular residual disease (MRD), empowering treatment decisions with greater insight and confidence. Pathlight™, the company’s flagship product, is an ultra-sensitive, blood-based, multi-cancer MRD test that is now available for commercial use in the U.S. for patients with breast cancer. SAGA is partnering with pharmaceutical and biotechnology companies, as well as commercial entities, to support early through late-stage cancer development programs across a range of cancer types.
sagadiagnostics.com

SOPHiA GENETICS

SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally.
sophiagenetics.com

STEMCELL Technologies Inc.

STEMCELL Technologies Inc.

STEMCELL Technologies supports liquid biopsy research with reproducible whole blood processing and preanalytical workflow solutions. From sample preparation, including cell and extracellular vesicle (EV) isolation, to scalable automation with RoboSep™, our tools streamline workflows and ensure consistent results. Visit Booth #306 or www.STEMCELL.com to learn more.
www.stemcell.com/

Tempus

Tempus

Tempus is a technology company leading the adoption of Al to advance precision medicine and patient care.
tempus.com

Tethis S.p.A.

Tethis S.p.A.

Tethis S.p.A., an Italian diagnostic company, is introducing the first automated platform that standardizes plasma and cytology sample preparations for multiomics liquid biopsy.
tethis-lab.com

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

#ISLB25

Confirmed Partners & Exhibitors

Organized By